CEACAM5 and neoplasm: In 1993, Ward et al. first found that a decrease in CEA was associated with tumor response and a CEA increase was associated with disease progression; however, their study only included 33 patients, and no visible trend in the change in patients’ CEA concentrations at different time points was shown [13].